Name | AR420626 |
---|---|
Synonyms |
3-Quinolinecarboxamide, N-(2,5-dichlorophenyl)-4-(2-furanyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-
AR420626 N-(2,5-Dichlorophenyl)-4-(2-furyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide N-(2,5-Dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxamide AR 420626 MFCD28987470 |
Description | AR420626 is a selective agonist of free fatty acid receptor 3 (FFAR3, GPR41) with IC50 of 117 nM. AR420626 inhibits nicotine and serotonin-induced changes in motility of isolated muscle strips from rat colon and suppresses serotonin-induced fecal output in rats[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 619.3±55.0 °C at 760 mmHg |
Molecular Formula | C21H18Cl2N2O3 |
Molecular Weight | 417.285 |
Flash Point | 328.3±31.5 °C |
Exact Mass | 416.069458 |
LogP | 3.71 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.653 |